Risk Factors for New-Onset Diabetes Mellitus after Heart Transplantation in Chinese Patients: A Single Center Experience

2019 ◽  
Vol 74 (4) ◽  
pp. 331-338 ◽  
Author(s):  
Min Zhang ◽  
Yong Han ◽  
Yonghua Yuan ◽  
Jie Cai ◽  
Jing Zhang ◽  
...  

Background: New-onset diabetes after transplantation ­(NODAT) is a frequent complication after heart transplantation (HT) and is associated with graft loss and patient survival. Objectives: The aim of this study was to identify the incidence and associated factors contributing to NODAT in Chinese heart transplant recipients. Methods: Adult patients without diabetes mellitus before HT were enrolled in this study. NODAT was diagnosed according to the criteria recommended by the American Diabetes Association. The cumulative incidence was determined at 3, 6, and 12 months, respectively. The risk factors of NODAT were estimated by logistic regression analysis. Results: A total of 154 adults who first received HT were included. Among them, 50 (32.5%) recipients were diagnosed with NODAT after a median follow-up time of 611 days. The cumulative incidence of NODAT was 27.3% at 3 months, 29.9% at 6 months, and 30.5% at 12 months, respectively. Independent risk factors for NODAT included age ≥45 years (OR 3.82, 95% CI 1.57–9.31; p = 0.003), hypertension (OR 3.28, 95% CI 1.17–9.20; p= 0.024), and transient hyperglycemia (OR 12.13, 95% CI 3.35–43.92; p < 0.001). Moreover, recipients treated with both acarbose and insulin for transient hyperglycemia had a significantly higher prevalence of NODAT than those without any anti-diabetic agents (OR 5.35, 95% CI 1.21–23.64; p = 0.027). Conclusions: Age ≥45 years, hypertension, transient hyperglycemia, and associated treatment strategies are imperative to identify recipients at high risk of developing ­NODAT.

2017 ◽  
Vol 81 (6) ◽  
pp. 806-814 ◽  
Author(s):  
Ho Jin Kim ◽  
Sung-Ho Jung ◽  
Jae-Joong Kim ◽  
Tae-Jin Yun ◽  
Joon Bum Kim ◽  
...  

2016 ◽  
Vol 20 (7) ◽  
pp. 963-969 ◽  
Author(s):  
Swati Sehgal ◽  
Matthew J. Bock ◽  
Hannah Louks Palac ◽  
Wendy J. Brickman ◽  
Jeffrey G. Gossett ◽  
...  

2021 ◽  
Vol Volume 14 ◽  
pp. 4783-4792
Author(s):  
Jushan Sun ◽  
Yibiao He ◽  
Lei Bai ◽  
Zhipeng Wang ◽  
Zhu Cao ◽  
...  

2020 ◽  
Vol 8 (2) ◽  
pp. e001778
Author(s):  
Menghua Dai ◽  
Cheng Xing ◽  
Ning Shi ◽  
Shunda Wang ◽  
Guangdong Wu ◽  
...  

IntroductionSeveral previous studies have reported the incidence of new-onset diabetes mellitus (NODM) after pancreatectomy. Nevertheless, the results were inconsistent. The true rate of NODM after distal pancreatectomy (DP) is still unknown.Research design and methodsThe aim of this study was to investigate the incidence of and the risk factors for NODM after DP. This study enrolled patients who underwent DP between January 2004 and February 2016 at Peking Union Medical College Hospital. Patients with preoperative diabetes mellitus or diagnosed with pancreatic cancer were excluded. The primary outcome was NODM.ResultsA total of 485 patients were enrolled. The median (IQR) of follow-up duration was 30.95 (9.26–180.30) months. The accumulative incidence of NODM was 8.9% at postoperative 6 months, 14.0% at postoperative year one, 22.3% at year three, 27.1% at year five, and 35.5% at year ten. Multivariate analysis showed that the risk of postoperative NODM was positively correlated with age (HR 1.029 (1.013–1.045), p<0.001), preoperative body mass index (BMI) (HR 1.042 (1.003–1.083), p=0.001), operative blood loss (HR 1.0003 (1.0002–1.0010), p<0.001), and length of resected pancreas (HR 1.079 (1.013–1.148), p=0.017). Moreover, concomitant splenectomy (HR 2.001 (1.202–3.331), p=0.008) was associated with significantly higher risk of postoperative NODM.ConclusionNODM incidence increased with postoperative time progression. Age, BMI, surgical blood loss, length of resected pancreas and splenectomy were independent risk factors for NODM after DP.Trial registration numberNCT03030209.


Sign in / Sign up

Export Citation Format

Share Document